Basics Lineage Cell Therapeutics, Inc. IPO Date: April 1, 1992 Sector: Healthcare Industry: Biotech Market Cap: $228.36M Activated in VL: True Average Daily Range Avg Daily Range: $0.05 | 3.77% Avg Daily Range (30 D): $0.04 | 4.61% Avg Daily Range (90 D): $0.03 | 4.36% Institutional Daily Volume Avg Daily Volume: .82M Avg Daily Volume (30 D): 2.55M Avg Daily Volume (90 D): 1.57M Trade Size Avg Trade Size (Sh.): 273 Avg Trade Size (Sh.) (30 D): 415 Avg Trade Size (Sh.) (90 D): 357 Institutional Trades Total Inst.Trades: 45 Avg Inst. Trade: $3.6M Avg Inst. Trade (30 D): $4.67M Avg Inst. Trade (90 D): $3.99M Avg Inst. Trade Volume: 2.8M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.82M Avg Closing Trade (30 D): $7.51M Avg Closing Trade (90 D): $5.42M Avg Closing Volume: 4.5M     News Feb 11, 2025 @ 9:45 AM Refrigerated Warehousing Market Revenues to Grow f... Source: Researchandmarkets.Com Oct 8, 2024 @ 9:00 AM ORBCOMM joins Move to -15°C coalition to promot... Source: Orbcomm Sep 21, 2024 @ 10:36 PM W.P. Carey: Buy, Sell, or Hold? Source: Courtney Carlsen Jul 16, 2024 @ 11:39 AM Cold storage REIT Lineage aims to raise up to $3.8... Source: Reuters Jan 6, 2024 @ 10:58 AM The Russell 2000 Index has soared, but you might b... Source: MarketWatch Financials   TTM Q4 2024 FY 2024 Basic EPS $-.02 $-.01 $-.09 Diluted EPS $-.02 $-.01 $-.09 Revenue $ 1.5M $ 2.87M $ 9.5M Gross Profit $ 1.47M $ 2.71M $ 9.17M Net Income / Loss $ -4.14M $ -3.25M $ -18.58M Operating Income / Loss $ -6.51M $ -5.11M $ -21.48M Cost of Revenue $ .04M $ .15M $ .33M Net Cash Flow $ 1.99M $ 18.05M $ 10.36M PE Ratio